← 產業報告目錄

Regenerative Medicine (Bone and Joint) Market, By Technology (Stem Cell, Biomaterial, Tissue Engineering), By Application (Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Bones, Autogenic Bones, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

出版商 Coherent Market Insights出版日期 2026-07-13頁數 259報告編號 CMR-cc44958902

授權報價

Single User Price$4,500 USD
Site License Price$7,000 USD
Enterprisewide Price (Global Site License)$10,000 USD
洽詢購買 申請 Sample

報告摘要

Regenerative medicine is a biological heterogeneous domain that incorporates material science, engineering, medicine, biological science, and surgery. It acts therapeutically by augmenting and stimulating the body’s capacity for regeneration and self-repair. Regenerative medicine involves the development of methods to regrow, repair or replace either the damaged or diseased cells, organs or tissues. This medicinal branch includes the generation and usage of stem cells and tissue engineering. Moreover, Major players in the market are also focused on expanding their capabilities. For instance, in March 2020, BioStem Life Sciences, a subsidiary of BioStem Technologies Inc. and a developer of regenerative therapies, announced to add R&D laboratory to its Florida, U.S. facility. Market Dynamics Key companies focusing on product approvals in regenerative medicine is expected to drive the global regenerative medicine (Bone and Joint) market growth. For instance, in 2017, Karl Schumacher Dental, LLC launched its new range of regenerative products, which include allograft, xenograft, and synthetic and collagen membranes. Moreover, adoption of 3D printing technology in regenerative medicine (bone and joint) is expected to aid in growth of the global regenerative medicine (bone and joint) market. For instance, in February 2020, researchers from Wake Forest School of Medicine, U.S. reported investigation of the effects of neural cell integration into the bioprinted skeletal muscle construct to accelerate functional muscle regeneration in vivo. Furthermore, High prevalence of arthritis is expected to propel growth of the global regenerative medicine (bone and joint) market over the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC)’s May 2019 report, around 54.4 million U.S. adults had diagnosed arthritis, which accounted for around 1 in 4 people in the U.S. Key features of the study: • This report provides in-depth analysis of the global regenerative medicine (bone and joint) market, and provides market size (US$ Bn) and compound annual growth rate (CAGR) (%) for the forecast period (2026-2033) • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, regional outlook, and competitive strategies adopted by the leading players. • It profiles leading players in the global regenerative medicine (bone and joint) market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansions and marketing tactics • The global regenerative medicine (bone and joint) market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts • The key players operating in global regenerative medicine (Bone and Joint) market include Anika Therapeutics, Inc, Arthrex, Inc., Baxter International, Inc., CONMED Corporation, Johnson & Johnson, Medtronic, Plc, Smith & Nephew plc, Stryker Corporation, Zimmer Holdings, Inc., Aziyo Biologics, and Ortho Regenerative Technologies Inc. • Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global regenerative medicine (bone and joint) market Market Segmentation • By Technology (Revenue, USD Bn, 2021-2033) o Stem Cell o Biomaterial o Tissue Engineering • By Application (Revenue, USD Bn, 2021-2033) o Bone Graft Substitutes o Osteoarticular Diseases o Allogeneic Bones o Autogenic Bones o Others • By Region (Revenue, USD Bn, 2021-2033) o North America  U.S.  Canada o Latin America  Brazil  Mexico  Argentina  Rest of Latin America o Europe  Germany  U.K.  France  Italy  Spain  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  South Africa  Central Africa  North Africa • Key Players o Anika Therapeutics, Inc o Arthrex, Inc. o Baxter International, Inc. o CONMED Corporation o Johnson & Johnson o Medtronic, Plc o Smith & Nephew plc o Stryker Corporation o Zimmer Holdings, Inc. o Aziyo Biologics o Ortho Regenerative Technologies Inc.
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Overview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Technology  Market Snapshot, By Application  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o Key Developments o Disease Type Approval o Collaboration/Merge/Acquisition o Regulatory Landscape o PEST Analysis o Porter’s Five Forces Analysis o Epidemiology o Robust Pipeline Analysis 4. Global Regenerative Medicine (Bone and Joint) Market, By Technology, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o Stem Cell  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Biomaterial  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Tissue Engineering  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) 5. Global Regenerative Medicine (Bone and Joint) Market, By Application, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o Bone Graft Substitutes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Osteoarticular Diseases  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Allogeneic Bones  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Autogenic Bones  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) 6. Global Regenerative Medicine (Bone and Joint) Market, By Region, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2022–2033  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Billion) o North Africa o Central Africa o South Africa 7. Competitive Landscape o Heat Map Analysis o Market Share Analysis o Company Profile  Anika Therapeutics, Inc o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Arthrex, Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Baxter International, Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  CONMED Corporation o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Johnson & Johnson o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Medtronic, Plc o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Smith & Nephew plc o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Stryker Corporation o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Zimmer Holdings, Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Aziyo Biologics o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Ortho Regenerative Technologies Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies o Analyst Views 8. Section o References o Research Methodology o About Us
圖表清單 List of Tables & Figures
NA NA

提及公司

o Anika TherapeuticsInco ArthrexInc.o Baxter InternationalInc.o CONMED Corporationo Johnson & Johnsono MedtronicPlco Smith & Nephew plco Stryker Corporationo Zimmer HoldingsInc.o Aziyo Biologicso Ortho Regenerative Technologies Inc.

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們